BR0107655A - Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica - Google Patents

Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica

Info

Publication number
BR0107655A
BR0107655A BR0107655-8A BR0107655A BR0107655A BR 0107655 A BR0107655 A BR 0107655A BR 0107655 A BR0107655 A BR 0107655A BR 0107655 A BR0107655 A BR 0107655A
Authority
BR
Brazil
Prior art keywords
polypeptide
cell
pharmaceutical composition
expression vector
recombinant expression
Prior art date
Application number
BR0107655-8A
Other languages
English (en)
Inventor
Sietse Mosselman
Petrus Johannes Spek Van Der
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0107655A publication Critical patent/BR0107655A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"POLINUCLEOTìDEO ISOLADO, VETOR DE EXPRESSãO RECOMBINANTE, POLIPEPTìDEO, CéLULA, MéTODO PARA PRODUZIR O POLIPEPTìDEO, E, COMPOSIçãO FARMACêUTICA". A invenção refere-se às seq³ências de DNA recentemente identificadas que codificam um novo polipeptídeo nó de cistina bem como à proteína codificada. A invenção é útil no campo da fertilidade.
BR0107655-8A 2000-01-18 2001-01-17 Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica BR0107655A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200185 2000-01-18
PCT/EP2001/000570 WO2001053346A1 (en) 2000-01-18 2001-01-17 Human cystine knot polypeptide

Publications (1)

Publication Number Publication Date
BR0107655A true BR0107655A (pt) 2002-10-15

Family

ID=8170926

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107655-8A BR0107655A (pt) 2000-01-18 2001-01-17 Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica

Country Status (9)

Country Link
US (1) US20030059877A1 (pt)
EP (1) EP1254175A1 (pt)
JP (1) JP2003520591A (pt)
CN (1) CN1395580A (pt)
AU (1) AU781389B2 (pt)
BR (1) BR0107655A (pt)
CA (1) CA2396283A1 (pt)
IL (1) IL150231A0 (pt)
WO (1) WO2001053346A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030143695A1 (en) * 1999-12-17 2003-07-31 Shuji Hinuma Novel polypeptide and dna thereof
US7514239B2 (en) * 2000-03-28 2009-04-07 Amgen Inc. Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
US20030219786A1 (en) * 2000-08-11 2003-11-27 Applied Research Systems Ars Holding N.V. Novel glycoproteins and methods of use thereof
US20040005554A1 (en) * 2000-05-08 2004-01-08 Tayar Nabil El Novel glycoproteins and methods of use thereof
AU2001283319A1 (en) * 2000-08-11 2002-02-25 Applied Research Systems Ars Holding N.V. Glycoproteins and methods of use thereof
EP1861417B1 (en) * 2005-03-10 2013-05-15 BioNTech AG Dimeric or multimeric microproteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143695A1 (en) * 1999-12-17 2003-07-31 Shuji Hinuma Novel polypeptide and dna thereof
US20020160953A1 (en) * 2000-04-25 2002-10-31 Holloway James L. Mammalian glycoprotein hormone-1
JP2004521952A (ja) * 2001-07-13 2004-07-22 ザイモジェネティクス，インコーポレイティド 脂肪分解を誘発するためのコルチコトロフ−誘導の糖タンパク質ホルモンの使用

Also Published As

Publication number Publication date
US20030059877A1 (en) 2003-03-27
WO2001053346A1 (en) 2001-07-26
AU3732001A (en) 2001-07-31
AU781389B2 (en) 2005-05-19
JP2003520591A (ja) 2003-07-08
EP1254175A1 (en) 2002-11-06
IL150231A0 (en) 2002-12-01
CA2396283A1 (en) 2001-07-26
CN1395580A (zh) 2003-02-05

Similar Documents

Publication Publication Date Title
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
FI961886A (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
BR0009392A (pt) Polipeptìdeo, sequência de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir uma sequência de ácido nucleico mutante e para produzir um polipeptìdeo, mutante de um polipeptìdeo com atividade de alafa-amilase, e, uso do polipeptìdeo ou variante
ATE446313T1 (de) Muteine von tränen-lipocalin
BRPI0109131B8 (pt) dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
DK289688A (da) Ekspression af proapolipoprotein a-i.
BR0207325A (pt) Métodos terapêuticos para doenças associadas com expressão diminuìda de gene de aop-1 ou aop-1
BR0113286A (pt) Pirazóis substituìdos
AR036202A1 (es) Composiciones y metodos relacionados con el cluster genico biosintetico de daptomicina
ATE304603T1 (de) Induzierendes alphavirengen- expressionssystem
BR0107655A (pt) Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica
BR0313455A (pt) modulação "antisense" da expressão de nav1.3
SE9801455D0 (sv) New receptor
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
FI930626A (fi) Proteinstruktur hos vaexttoxingelonin
BR9407693A (pt) Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto
BR9902019A (pt) Moléculas de polinucleotìdios que codificam proteìnas de neospora.
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
DE69529235T2 (de) Menschliche dnase i varianten
BR0113623A (pt) Proteìnas sintéticas de estìmulo da eritropoiese
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
BR0017015A (pt) Toxina estafilocócica modificada, gene codificante, vetor de expressão, célula e métodos de produção de polipeptìdeo, de separação e purificação da toxina e de, produção de vacina.
BR9915537A (pt) Gene prv-1 e sua utilização

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.